Activation of SAPK/JNK by camptothecin sensitizes androgen-independent prostate cancer cells to Fas-induced apoptosis
2000
Camptothecin Helps Prostate Cancer Cells Die
publication
Author Information
Author(s): Costa-Pereira A P, McKenna S L, Cotter T G
Primary Institution: University College, Ireland
Hypothesis
Can camptothecin sensitize androgen-independent prostate cancer cells to Fas-induced apoptosis?
Conclusion
Camptothecin activates SAPK/JNK, which is necessary for sensitizing prostate cancer cells to apoptosis triggered by Fas.
Supporting Evidence
- Androgen-independent prostate cancer cells were resistant to anti-Fas-induced apoptosis.
- Camptothecin pretreatment overcame this resistance.
- SAPK/JNK activity is required for the sensitization effect of camptothecin.
Takeaway
This study found that a drug called camptothecin can help certain prostate cancer cells die when combined with another treatment.
Methodology
The study involved treating prostate cancer cells with camptothecin and assessing the activation of SAPK/JNK and apoptosis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website